Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil
about
Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil
description
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Low-dose eribulin mesylate exe ...... gistically with 5-fluorouracil
@en
Low-dose eribulin mesylate exe ...... gistically with 5-fluorouracil
@nl
type
label
Low-dose eribulin mesylate exe ...... gistically with 5-fluorouracil
@en
Low-dose eribulin mesylate exe ...... gistically with 5-fluorouracil
@nl
prefLabel
Low-dose eribulin mesylate exe ...... gistically with 5-fluorouracil
@en
Low-dose eribulin mesylate exe ...... gistically with 5-fluorouracil
@nl
P2093
P2860
P356
P1476
Low-dose eribulin mesylate exe ...... gistically with 5-fluorouracil
@en
P2093
Hidehiro Tajima
Itasu Ninomiya
Jun Kinoshita
Katsunobu Oyama
Mitsuyoshi Okazaki
Sachio Fushida
Takahisa Yamaguchi
Tetsuo Ohta
Tomoharu Miyashita
Toru Kurata
P2860
P304
P356
10.2147/CMAR.S167846
P407
P577
2018-01-01T00:00:00Z